Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic

Fig. 1

Impact of iPSC-MSCs treatment on enhancing the capacity of anti-inflammation and immunomodulation. A Flow-cytometric analytical result of M2 to M1 ratio. B–E Immunofluorescent (IF) microscopic finding (400x) for identification of positively-stained macrophage migration inhibitory factor (MIF) cells (green color). Scale bars in right lower corner represent 20 µm. F Analytical result of number of MIF + cells. G Protein expression of tumor necrosis factor (TNF-α). H Protein expression of interleukin (IL)-6. I Protein expression of IL-10. n = 4 or 6 for each group. * indicates p value < 0.05; ** indicates p value  < 0.01; *** indicates p value  < 0.001. iPS-MSCs = induced pluripotent stem cells-derived mesenchymal stem cells; LPS = lipopolysaccharide

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512